James Hassard

Companies

• Crinetics PharmaceuticalsChief Commercial Officer Mar 9, 2022 to Jul 9, 2024¹
• Arrowhead PharmaceuticalsChief Commercial Officer Jan 13, 2020 to Jun 24, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Crinetics Pharmaceuticals29,259 shares³Jul 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 5, 2024Sold 15,000 shares at $44.08 of Crinetics Pharmaceuticals³
• Jul 5, 2024Exercised options 15,000 shares at $19.73 of Crinetics Pharmaceuticals³
• Jun 21, 2024Sold 15,000 shares at $44.66 of Crinetics Pharmaceuticals⁴
• Jun 21, 2024Exercised options 15,000 shares at $19.73 of Crinetics Pharmaceuticals⁴
• Mar 18, 2024Shares withheld for tax 1,741 shares at $38.14 of Crinetics Pharmaceuticals⁵
• Mar 4, 2024Granted 17,000 shares of Crinetics Pharmaceuticals⁶
• Mar 1, 2023Granted 14,000 shares of Crinetics Pharmaceuticals⁷